ANDA 88326, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88326 (Lidocaine Hydrochloride In Plastic Container), held by Hospira, was first approved by FDA on Jul 31, 1984, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride In Plastic Container1.5% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Oct 22, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 8Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Apr 18, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Jul 31, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters